Advancing Voluntary, Informed Consent to Medical Intervention
Sin Hang Lee, MD, FRCP
Sin Hang Lee, MD, F.R.C.P. Pathologist
Dr. Sin Lee is a pathologist who has been practicing for 40 years: as the attending Pathologist at Yale from 1973 to 2003. He was the Director of the Molecular Diagnostic Section at Milford Medical Laboratory from 2004 to 2015. Since 2015, he is the Director of the Milford Molecular Diagnostics Laboratory.
Dr. Lee was born in Hong Kong, and received his medical degree from Tongji-Wuhan Medical University in China. He is a naturalized U.S. citizen, and a licensed medical doctor in in DC, New York, and Connecticut, in Canada, and is certified by the General Medical Council in London, and is a Certificated Specialist and is a fellow at the Royal College of Physicians and Surgeons in Canada.. He is board certified pathologist by the American Board of Pathology. His expertise includes General pathology, surgical pathology, clinical microbiology and molecular diagnostics by PCR/direct DNA.
Dr. Lee developed two accurate DNA screening tests to improve treatment outcomes. The first test detects Lyme disease at an early stage, before the disease becomes chronic, thereby greatly improving treatment outcomes .The second is a DNA test to accurately detect cervical cancer, thereby eliminating unnecessary colposcopic biopsies which are performed too often. Dr. Lee has conducted HPV DNA research involving the vaccine Gardasil, at the request of mothers whose daughters developed severe adverse reactions after HPV vaccination.
Dr. Lee’s publications include:
Single Core Genome Sequencing for Detection of both Borrelia burgdorferi Sensu Lato and Relapsing Fever Borrelia Species, International Journal of Environmental Research in PublicHealth, 2019
Metagenomic …Gene Sequencing Survey of Borrelia Speciess…PLoS One, 2019
Lyme Disease Caused by Borrelia Burgdorferi…Int’l Medical Case Reports Journal, 2016
From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention. Cancers, 2014
Detection of Borreliae in Archived Sera from Patients with Clinically Suspect Lyme Disease. International Journal of Molecular Sciences (IJMS).
…Mutation Screen on Pap Smear Cytology Samples. IJMS, 2016
From HPV Detection to Cervical Cancer Prevention. Cancers (Basel). 2014
Melting Profiles May Affect Detection Of Residual HPV L1 Gene DNA Fragments In Gardasil®. Current Med Chem. 2014
In an unprecedented anti-trust lawsuit, filed suit in federal court in October 2017, Dr. Lee accused the Centers for Disease Control and Prevention (CDC) of suppressing the use of his more accurate DNA Lyme detection test, and continues to endorse a less accurate serology test. His lawyer uncovered evidence of financial conflicts of interest; several CDC officials receive royalties for each of the faulty Lyme disease tests administered, and they will continue to receive money as long as these faulty tests are being used.
Dr. Lee laments the undue influence that industry has exerted on the practice of medicine: “It is unfortunate that the medical profession has become part of the healthcare industry and physicians are now classified as service providers.”